Chelsea Therapeutics Intl Ltd fka CHIP

[Clemsontiger]

Great approval. My expectation was label restriction for two week use. That did not happen. warning of supine hypertension is ok with me. Without restriction since this is a safe drug, it can be prescribed for longer duration.

Good for patients, good for stock and revenues.....Win Win for all.

Based on this rather straightforward approval, I expect the buyout to happen quickly. One drug, no pipeline, simple valuation, orphan status.

TEVA or Shire would be good suitors. Shire can just convert the scripts as their drug phases out..